semaglutide news november 28 2025 The FDA has approved a new higher dose (7.2 mg) of Wegovy (semaglutide) injection, Wegovy HD, for weight loss and long-term weight maintenance in certain adult patients—in just 54 days from filing Wegovy Users More Likely to
Description
Most clinicians recommend stopping the medication at least two months before trying for a baby
Krivic A, et al
Disclaimer: This compound is sold for in vitro research and educational purposes only
Same weekly cadence as Phase 2 with intensity increased: RF medium to medium-high if tolerated, longer microcurrent sessions (12 to 15 minutes), same LED dosing
Pregnancy & Planning Strictly prohibited during pregnancy or lactation
The 4.8 mg dose emerged as the optimal balance between efficacy and tolerability
